T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.

<h4>Objective</h4>Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrea Cossarizza, Linda Bertoncelli, Elisa Nemes, Enrico Lugli, Marcello Pinti, Milena Nasi, Sara De Biasi, Lara Gibellini, Jonas P Montagna, Marco Vecchia, Lisa Manzini, Marianna Meschiari, Vanni Borghi, Giovanni Guaraldi, Cristina Mussini
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4ef44ddb568c45ffa319473c6ce6d456
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ef44ddb568c45ffa319473c6ce6d456
record_format dspace
spelling oai:doaj.org-article:4ef44ddb568c45ffa319473c6ce6d4562021-11-18T08:06:04ZT cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.1932-620310.1371/journal.pone.0050728https://doaj.org/article/4ef44ddb568c45ffa319473c6ce6d4562012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23236388/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to disease progression.<h4>Patients and methods</h4>We followed 11 patients experiencing PHI for 4 years. By polychromatic flow cytometry, we studied every month, for the first 6 months, T lymphocyte polyfunctionality after cell stimulation with peptides derived from HIV-1 gag and nef. Tregs were identified by flow cytometry, and T cell activation studied by CD38 and HLA-DR expression.<h4>Results</h4>An increase of anti-gag and anti-nef CD8+ specific T cells was observed 3 months after PHI; however, truly polyfunctional T cells, also able to produce IL-2, were never found. No gross changes in Tregs were present. T lymphocyte activation was maximal 1 and 2 months after PHI, and significantly decreased in the following period. The level of activation two months after PHI was strictly correlated to the plasma viral load 1 year after infection, and significantly influenced the length of period without therapy. Indeed, 80% of patients with less than the median value of activated CD8+ (15.5%) or CD4+ (0.9%) T cells remained free of therapy for >46 months, while all patients over the median value had to start treatment within 26 months.<h4>Conclusions</h4>T cell activation after PHI, more than T cell polyfunctionality or Tregs, is a predictive marker for the control of viral load and for the time required to start treatment.Andrea CossarizzaLinda BertoncelliElisa NemesEnrico LugliMarcello PintiMilena NasiSara De BiasiLara GibelliniJonas P MontagnaMarco VecchiaLisa ManziniMarianna MeschiariVanni BorghiGiovanni GuaraldiCristina MussiniPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e50728 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Andrea Cossarizza
Linda Bertoncelli
Elisa Nemes
Enrico Lugli
Marcello Pinti
Milena Nasi
Sara De Biasi
Lara Gibellini
Jonas P Montagna
Marco Vecchia
Lisa Manzini
Marianna Meschiari
Vanni Borghi
Giovanni Guaraldi
Cristina Mussini
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
description <h4>Objective</h4>Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to disease progression.<h4>Patients and methods</h4>We followed 11 patients experiencing PHI for 4 years. By polychromatic flow cytometry, we studied every month, for the first 6 months, T lymphocyte polyfunctionality after cell stimulation with peptides derived from HIV-1 gag and nef. Tregs were identified by flow cytometry, and T cell activation studied by CD38 and HLA-DR expression.<h4>Results</h4>An increase of anti-gag and anti-nef CD8+ specific T cells was observed 3 months after PHI; however, truly polyfunctional T cells, also able to produce IL-2, were never found. No gross changes in Tregs were present. T lymphocyte activation was maximal 1 and 2 months after PHI, and significantly decreased in the following period. The level of activation two months after PHI was strictly correlated to the plasma viral load 1 year after infection, and significantly influenced the length of period without therapy. Indeed, 80% of patients with less than the median value of activated CD8+ (15.5%) or CD4+ (0.9%) T cells remained free of therapy for >46 months, while all patients over the median value had to start treatment within 26 months.<h4>Conclusions</h4>T cell activation after PHI, more than T cell polyfunctionality or Tregs, is a predictive marker for the control of viral load and for the time required to start treatment.
format article
author Andrea Cossarizza
Linda Bertoncelli
Elisa Nemes
Enrico Lugli
Marcello Pinti
Milena Nasi
Sara De Biasi
Lara Gibellini
Jonas P Montagna
Marco Vecchia
Lisa Manzini
Marianna Meschiari
Vanni Borghi
Giovanni Guaraldi
Cristina Mussini
author_facet Andrea Cossarizza
Linda Bertoncelli
Elisa Nemes
Enrico Lugli
Marcello Pinti
Milena Nasi
Sara De Biasi
Lara Gibellini
Jonas P Montagna
Marco Vecchia
Lisa Manzini
Marianna Meschiari
Vanni Borghi
Giovanni Guaraldi
Cristina Mussini
author_sort Andrea Cossarizza
title T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
title_short T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
title_full T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
title_fullStr T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
title_full_unstemmed T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
title_sort t cell activation but not polyfunctionality after primary hiv infection predicts control of viral load and length of the time without therapy.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/4ef44ddb568c45ffa319473c6ce6d456
work_keys_str_mv AT andreacossarizza tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT lindabertoncelli tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT elisanemes tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT enricolugli tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT marcellopinti tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT milenanasi tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT saradebiasi tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT laragibellini tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT jonaspmontagna tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT marcovecchia tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT lisamanzini tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT mariannameschiari tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT vanniborghi tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT giovanniguaraldi tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
AT cristinamussini tcellactivationbutnotpolyfunctionalityafterprimaryhivinfectionpredictscontrolofviralloadandlengthofthetimewithouttherapy
_version_ 1718422226108153856